Stallion India Fluorochemicals Limited has informed the Exchange about Investor Presentation
STALLION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Stallion India Fluorochemicals reported strong FY25 results with total revenue rising to ₹379.47 Cr from ₹236.23 Cr in FY24 (up ~60%) and EBITDA nearly doubling to ₹49.74 Cr from ₹26.86 Cr. FY25 PAT came in at ₹32.33 Cr, but included a one-time ₹10.71 Cr provision for an old claim settlement — excluding this, PAT would have been ₹43.04 Cr. EBITDA margin expanded to 13.11% from 11.37%, and ROCE improved to 20.89%. Q4 FY25 was particularly strong with revenue of ₹153.16 Cr (up 80% QoQ) and PAT of ₹13.27 Cr. Management outlined plans to add two new facilities (including a semiconductor and specialty gas plant in Mambattu, Andhra Pradesh), enter liquid helium processing (1,200 MT per annum), and target 30-35% revenue CAGR over the next 3 years with 3-4% margin improvement.
The sharp revenue and earnings growth, combined with margin expansion and a clear 3-year growth roadmap, is positive for shareholders. However, the one-time ₹10.71 Cr provision for an old claim is a minor drag on reported FY25 PAT, though the underlying business momentum remains strong.